Why the study?
NF-κB is implicated in aging tissues and increased in aging hearts, but its in vivo role in aging-related cardiac alterations and senescence remained to be determined.
Does cardiomyocyte-specific NF-κB suppression prevent aging-associated cardiac remodeling and dysfunction in mice?
Does cardiomyocyte-specific NF-κB suppression prevent aging-associated cardiac remodeling and dysfunction in mice?
Cardiomyocyte-specific suppression of NF-κB exacerbates aging-associated cardiac remodeling, dysfunction, and cellular senescence, suggesting a critical baseline role for NF-κB in maintaining cardiac homeostasis during aging.
Cardiomyocyte NF-κB suppression worsens aging-related cardiac dysfunction in mice; leaves open its therapeutic targeting in human HF.
Background/Objectives: Aging is associated with structural and functional changes in the heart, including hypertrophy, fibrosis, and impaired contractility. Cellular mechanisms such as senescence, telomere shortening, and DNA damage contribute to these processes. Nuclear factor kappa B (NF-κB) has been implicated in mediating cellular responses in aging tissues, and increased NF-κB expression has been observed in the hearts of aging rodents. Therefore, NF-κB is suspected to play an important regulatory role in the cellular and molecular processes occurring in the heart during aging. This study investigates the in vivo role of NF-κB in aging-related cardiac alterations, focusing on senescence and associated cellular events. Methods: Young and old wild-type (WT) and transgenic male mice with cardiomyocyte-specific NF-κB suppression (3M) were used to assess cardiac function, morphology, senescence markers, lipofuscin deposition, DNA damage, and apoptosis. Results: Kaplan–Meier analysis revealed reduced survival in 3M mice compared to WT. Echocardiography showed evidence of eccentric hypertrophy, and both diastolic and systolic dysfunction in 3M mice. Both aged WT and 3M mice exhibited cardiac hypertrophy, with more pronounced hypertrophic changes in cardiomyocytes from 3M mice. Additionally, cardiac fibrosis, senescence-associated β-galactosidase activity, p21 protein expression, and DNA damage (marked by phosphorylated H2A.X) were elevated in aged WT and both young and aged 3M mice. Conclusions: The suppression of NF-κB in cardiomyocytes leads to pronounced cardiac remodeling, dysfunction, and cellular damage associated with the aging process. These findings suggest that NF-κB plays a critical regulatory role in cardiac aging, influencing both cellular senescence and molecular damage pathways. This has important implications for the development of therapeutic strategies aimed at mitigating age-related cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Morgado et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: